Astellas Pharma
Japanese pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Astellas Pharma?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
"Astellas" redirects here. For similar sounding terms, see Astelia, Astellia, Astell, Astelma, and Astala.
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha).
Quick Facts Company type, Traded as ...
Company type | Public (K.K) |
---|---|
Industry | Pharmaceutical |
Predecessors | Yamanouchi Pharmaceutical Fujisawa Pharmaceutical (Merged in 2005) |
Founded | 1 April 2005; 19 years ago (2005-04-01) |
Headquarters | 2-5-1, Nihonbashi-Honcho, Chūō-ku, Tokyo 103-8411, Japan |
Key people | Naoki Okamura (President and CEO) Kenji Yasukawa (Chairman of the Board) |
Products | |
Revenue | US$11,060,000,000 (FY 2013) |
US$1,280,000,000 (¥1,139,000,000,000) (FY 2013) | |
Total assets | $14.86 billion (2016)[1] |
Number of employees | 17,217 (2016)[2] |
Subsidiaries | Astellas US |
Website | www.astellas.com/en/ |
Footnotes / references [3][4][5] |
Close
Astellas is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.